These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23858528)

  • 21. [In situ hybridization in molecular pathological diagnostics].
    Schildhaus HU
    Pathologe; 2020 Nov; 41(6):561-562. PubMed ID: 33095304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Detection of epidermal growth factor receptor gene amplification in human laryngeal carcinomas by means of fluorescence in situ hybridization].
    Li F; Kang N; Fu W; Sun X; Gao H; Sun K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):278-80. PubMed ID: 10932015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial.
    Cappuzzo F; Ligorio C; Jänne PA; Toschi L; Rossi E; Trisolini R; Paioli D; Holmes AJ; Magrini E; Finocchiaro G; Bartolini S; Cancellieri A; Ciardiello F; Patelli M; Crino L; Varella-Garcia M
    J Clin Oncol; 2007 Jun; 25(16):2248-55. PubMed ID: 17538169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The New Equivocal: Changes to HER2 FISH Results When Applying the 2013 ASCO/CAP Guidelines.
    Long TH; Lawce H; Durum C; Moore SR; Olson SB; Gatter K; Troxell ML
    Am J Clin Pathol; 2015 Aug; 144(2):253-62. PubMed ID: 26185310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
    Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
    Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
    Hirsch FR; Varella-Garcia M; McCoy J; West H; Xavier AC; Gumerlock P; Bunn PA; Franklin WA; Crowley J; Gandara DR;
    J Clin Oncol; 2005 Oct; 23(28):6838-45. PubMed ID: 15998906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib.
    Wiedmann M; Feisthammel J; Blüthner T; Tannapfel A; Kamenz T; Kluge A; Mössner J; Caca K
    Anticancer Drugs; 2006 Aug; 17(7):783-95. PubMed ID: 16926628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidermal growth factor receptor family and targeted anticancer therapy].
    Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):577-9. PubMed ID: 17134561
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluorescence in situ hybridization in cancer and radiation biology.
    Gray JW; Pinkel D; Brown JM
    Radiat Res; 1994 Mar; 137(3):275-89. PubMed ID: 8146269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome prediction to erlotinib in gastroesophageal adenocarcinomas: can we improve epidermal growth factor receptor and phospho-AKT testing?
    Personeni N
    J Clin Oncol; 2007 Mar; 25(7):910; author reply 911. PubMed ID: 17327617
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
    Piris A; Scopsi L; Clemente C; Cetti Serbelloni F; Mihm MC; Hoang MP
    Am J Dermatopathol; 2010 Aug; 32(6):586-92. PubMed ID: 20534988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selecting patients for epidermal growth factor receptor inhibitor treatment: A FISH story or a tale of mutations?
    Johnson BE; Jänne PA
    J Clin Oncol; 2005 Oct; 23(28):6813-6. PubMed ID: 16145056
    [No Abstract]   [Full Text] [Related]  

  • 35. A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements.
    Kimura M; Tsuda H; Morita D; Ichikura T; Ogata S; Aida S; Yoshizumi Y; Maehara T; Mochizuki H; Matsubara O
    Virchows Arch; 2004 Sep; 445(3):255-62. PubMed ID: 15517369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of epidermal growth factor receptor amplification in malignant gliomas.
    Sauter G; Maeda T; Waldman FM; Davis RL; Feuerstein BG
    Am J Pathol; 1996 Apr; 148(4):1047-53. PubMed ID: 8644846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
    Buckley AF; Burgart LJ; Kakar S
    Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
    Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
    APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.